Ueber Pellote: Beiträge zur chemischen und pharmakologischen Kenntniss der Cacteen Zweite Mittheilung
Open accessThe DOI matches its Crossref record.
Abstract
Einleitung. Seit meiner ersten Mittheilung tiber den Pellote 1), in d e r n u r in Umrissen die Anwendung dieses interessanten Berausehungsmittels aus der Caeteenfamilie skizzirt werden konnte, sind unsere Kenntnisse tiber die Art und Ausdehnung des Gebrauehes wesentlich erweitert und vervollst~tndigt worden. Dass die Benutzung des Pellote oder Peyotl fiber mehrere Jahrhunderte zurtickreieht, geht aus den interessanten Ausftihrungen aus S a h a g u n , H e r n a n d e z u. A. hervor, die wir L e w i n ~) verdanken. Peyotl ist ein altes aztekisehes Wort. Es dlirfte aber nieht ganz zutreffend sein, wenn L e w i n behauptet, dass Pellote oder Peyotl ein Wort des niederen Volksjargons ist. Vielmehr gehSrt es der Tarahumarisprache an, wie aus einer Stelle bei B u s c h m a n n Z ) hervorgeht, die interessant genug ist, um sie unverktirzt hier anzufUhren. Naeh der Aufz~thlung der aztekisehen Wtirter in den mexikanischen Nordwestspraehen f~thrt B u s e h m a n n fort:
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Johnson, M. W., Hendricks, P. S., Barrett, F. S., & Griffiths, R. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.010 · Cited by 506
Adverse effects of psychedelics: From anecdotes and misinformation to systematic science
Schlag, A. K., Aday, J., Salam, I., Neill, J. C., & Nutt, D. J. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211069100 · Cited by 325
Potential Therapeutic Effects of Psilocybin
Johnson, M. W., & Griffiths, R. R. (2017) · Neurotherapeutics · doi:10.1007/s13311-017-0542-y · Cited by 296
Psychedelics as anti-inflammatory agents
Flanagan, T. W., & Nichols, C. D. (2018) · International Review of Psychiatry · doi:10.1080/09540261.2018.1481827 · Cited by 267
Classic hallucinogens in the treatment of addictions
Bogenschutz, M. P., & Johnson, M. W. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.03.002 · Cited by 226
“Classic hallucinogens have been used by humans for over 5000 years (El-Seedi et al., 2005), but scientific interest in hallucinogens dates to the late 1800s, when mescaline was isolated and its effects were described by Arthur Heffter (Heffter, 1896; Heffter, 1898).”
Galvão-Coelho, N. L., Marx, W., Gonzalez, M., Sinclair, J., de Manincor, M., Perkins, D., & Sarris, J. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05719-1 · Cited by 137
“Mescaline, usually derived from the peyote cactus (Bogenschutz and Ross 2018; Heffter 1898), and LSD were investigated in older psychiatric studies, conducted to explore effects on psychosis and alcoholism (Berlin et al. 1955; Blum et al. 1977; Fuentes et al. 2019; Gouzoulis-Mayfrank et al. 1998;…”
BackgroundWhy Are the Majority of Active Compounds in the CNS Domain Natural Products? A Critical Analysis
Bharate, S. S., Mignani, S., & Vishwakarma, R. A. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01922 · Cited by 102
Dark Classics in Chemical Neuroscience: Mescaline
Cassels, B. K., & Sáez-Briones, P. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00215 · Cited by 85
Differential phospholipase C activation by phenylalkylamine serotonin 5‐HT2Areceptor agonists
Parrish, J. C., Braden, M. R., Gundy, E., & Nichols, D. E. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03477.x · Cited by 41
“…discovery that mescaline (3,4,5- trimethoxyphenethylamine) was the active constituent of the hallucinogenic peyote cactus, Lophophora williamsii (Heffter 1898; Perrine 2001), the biochemical mechanism(s) responsible for altered states of consciousness (ASC) induced by hallucinogens is still…”
Background
Metadata
- Authors
- Heffter, A.
- Venue
- Archiv für Experimentelle Pathologie und Pharmakologie
- Published
- 1898-02
- Volume
- 40
- Issue
- 5-6
- Pages
- 385-429
- ISSN
- 0028-1298 (ISSN-L)
- 1432-1912
- OpenAlex
- W2315561580
- Cited by
- 77
- References
- 0
- FWCI
- 46.78
- Type
- journal article
- Language
- de
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.